<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/448539BD-1FB4-486D-9D7F-973FE0345F9D"><gtr:id>448539BD-1FB4-486D-9D7F-973FE0345F9D</gtr:id><gtr:name>Randox Laboratories Limited</gtr:name><gtr:address><gtr:line1>55 Diamond Road</gtr:line1><gtr:city>Crumlin</gtr:city><gtr:postCode>BT29 4QY</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/448539BD-1FB4-486D-9D7F-973FE0345F9D" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>448539BD-1FB4-486D-9D7F-973FE0345F9D</gtr:id><gtr:name>Randox Laboratories Limited</gtr:name><gtr:address><gtr:line1>55 Diamond Road</gtr:line1><gtr:city>Crumlin</gtr:city><gtr:postCode>BT29 4QY</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>357282.0</gtr:offerGrant><gtr:projectCost>1517885.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E208F1C3-F6F0-413A-BE26-436DF5B6A210" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E208F1C3-F6F0-413A-BE26-436DF5B6A210</gtr:id><gtr:name>Queen's University of Belfast Foundation -The</gtr:name><gtr:address><gtr:line1>Queen's University Belfast,Northern Ireland Technology Centre,8 Cloreen Park</gtr:line1><gtr:city>Belfast</gtr:city><gtr:postCode>BT9 5HN</gtr:postCode><gtr:region>Northern Ireland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>803319.0</gtr:offerGrant><gtr:projectCost>803319.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FED0688A-7F8C-4A77-AC29-2B995C3A8AE7"><gtr:id>FED0688A-7F8C-4A77-AC29-2B995C3A8AE7</gtr:id><gtr:firstName>Pauline</gtr:firstName><gtr:surname>Bradley</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101184"><gtr:id>B40F7FA1-6975-4349-8421-888B942B642E</gtr:id><gtr:title>Multiplex Point of Care detection of sepsis pathogens, using biochip array technology</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101184</gtr:grantReference><gtr:abstractText>Sepsis kills 30 000 people in the UK and costs the NHS &amp;pound;400 million per year. It is little known outside the medical profession but is the third most common cause of death in hospitalised patients outside of heart disease and cancer. It happens when an infection in the bloodstream tips the immune system out of balance and this system starts to attack the body rather than protect it. Many infections can potentially trigger sepsis but rapid treatment with the right antibiotic can often prevent it turning into serious sepsis. The Technology Strategy Board is supporting a group of teaching hospitals (St Thomas?s &amp;amp; Newcastle) in their work with BD (a US Heathcare Company with a base in Oxford) to develop a rapid test which can help doctors choose the right treatment during the critical early stages of the disease. This will save lives and reduce the huge cost of sepsis to the NHS.</gtr:abstractText><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1160601</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101184</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>